Bert Rein Comments on High-Profile First Amendment Supreme Court Case

Wiley Rein senior partner Bert W. Rein was referenced in the Wall Street Journal's Health Blog in an article on Sorrell v. IMS Health Inc., a First Amendment case heard by the U.S. Supreme Court on Tuesday, April 26. Sorrell challenges a Vermont law prohibiting the sale of prescription data to market drugs, unless prescribing doctors first consent. Mr. Rein told the paper that if pharmaceutical companies could no longer use prescribing information, there would be no one to subsidize its other non-commercial uses, including drug recalls.

Mr. Rein filed an amicus brief in the case on behalf of the patient advocacy groups Genetic Alliance and the National Organization for Rare Disorders. Last week, The National Law Journal's Supreme Court Insider recognized the filing as its "Brief of the Week."